STRATA Skin Sciences Inc Total Assets
STRATA Skin Sciences Inc total assets. Based on the latest financial reports, STRATA Skin Sciences Inc (SSKN) holds total assets worth $30.52 Million USD as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see STRATA Skin Sciences Inc (SSKN) total market value for the company's overall valuation and market capitalisation.
Total Assets of STRATA Skin Sciences Inc (2000–2025)
Total assets of STRATA Skin Sciences Inc from 2000 to 2025. This chart illustrates how STRATA Skin Sciences Inc's total assets have evolved over time, based on quarterly financial data. See SSKN share price today for real-time trading data and today's change.
STRATA Skin Sciences Inc - Asset Composition Analysis
STRATA Skin Sciences Inc Total Assets Breakdown (December 2025)
STRATA Skin Sciences Inc total assets breakdown as of December 2025. STRATA Skin Sciences Inc's total assets of $30.52 Million consist of 51.1% current assets and 48.9% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 25.9% |
| Accounts Receivable | $4.12 Million | 13.5% |
| Inventory | $2.81 Million | 9.2% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $3.38 Million | 11.1% |
| Goodwill | $1.43 Million | 4.7% |
Asset Composition Trend (2000–2025)
This chart illustrates how STRATA Skin Sciences Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore how liquid is STRATA Skin Sciences Inc's working capital to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: STRATA Skin Sciences Inc's current assets represent 51.1% of total assets in 2025, a decrease from 92.1% in 2000.
- Cash Position: Cash and equivalents constituted 25.9% of total assets in 2025, up from 0.0% in 2000.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 15.0% of total assets, an increase from 0.0% in 2000.
- Asset Diversification: The largest asset category is accounts receivable at 13.5% of total assets.
STRATA Skin Sciences Inc Competitors by Total Assets
Key competitors of STRATA Skin Sciences Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832
|
China | CN¥9.58 Billion |
|
Sinocare Inc
SHE:300298
|
China | CN¥6.25 Billion |
|
T&L Co. Ltd
KQ:340570
|
Korea | ₩253.22 Billion |
|
Paxman AB
ST:PAX
|
Sweden | Skr487.65 Million |
|
VIROMED MEDICAL NA O.N.
XETRA:VME
|
Germany | €13.91 Million |
|
Sequana Medical NV
BR:SEQUA
|
Belgium | €14.57 Million |
|
ORTOMA AB B
F:82Y
|
Germany | €161.34 Million |
|
Diagnostic Medical Systems SA
PA:ALDMS
|
France | €62.52 Million |
STRATA Skin Sciences Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.58 | 1.13 | 1.20 |
| Quick Ratio | 0.48 | 0.98 | 1.03 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-11.14 Million | $1.97 Million | $4.00 Million |
STRATA Skin Sciences Inc - Advanced Valuation Insights
This section examines the relationship between STRATA Skin Sciences Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.26 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -15.6% |
| Total Assets | $30.52 Million |
| Market Capitalization | $29.44K USD |
Valuation Analysis
Below Book Valuation: The market values STRATA Skin Sciences Inc's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: STRATA Skin Sciences Inc's assets decreased by 15.6% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for STRATA Skin Sciences Inc (2000–2025)
The table below shows the annual total assets of STRATA Skin Sciences Inc from 2000 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $30.52 Million | -15.59% |
| 2024-12-31 | $36.16 Million | -13.94% |
| 2023-12-31 | $42.02 Million | -19.62% |
| 2022-12-31 | $52.27 Million | +12.19% |
| 2021-12-31 | $46.59 Million | -0.40% |
| 2020-12-31 | $46.78 Million | -1.19% |
| 2019-12-31 | $47.34 Million | -0.35% |
| 2018-12-31 | $47.51 Million | +22.98% |
| 2017-12-31 | $38.63 Million | -10.56% |
| 2016-12-31 | $43.19 Million | -15.92% |
| 2015-12-31 | $51.37 Million | +155.96% |
| 2014-12-31 | $20.07 Million | +42.02% |
| 2013-12-31 | $14.13 Million | -18.17% |
| 2012-12-31 | $17.27 Million | -44.99% |
| 2011-12-31 | $31.39 Million | -6.54% |
| 2010-12-31 | $33.59 Million | +4.55% |
| 2009-12-31 | $32.13 Million | +93.31% |
| 2008-12-31 | $16.62 Million | -24.83% |
| 2007-12-31 | $22.11 Million | -1.64% |
| 2006-12-31 | $22.48 Million | +17.27% |
| 2005-12-31 | $19.17 Million | +170.09% |
| 2004-12-31 | $7.10 Million | +1542.63% |
| 2003-12-31 | $432.00K | +25.58% |
| 2002-12-31 | $344.00K | -69.58% |
| 2001-12-31 | $1.13 Million | -70.35% |
| 2000-12-31 | $3.81 Million | -- |
About STRATA Skin Sciences Inc
STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, China, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. It operates through Dermatology Recurring Procedures and Dermatology Procedures Equipment segments. The company offers XTRAC excimer … Read more